Reports of esophageal cancer with oral bisphosphonate use.

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37

Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ (2010) 4.92

Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA (2010) 3.37

Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data. BMJ (2013) 3.34

Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20

Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc (2013) 2.08

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50

More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 1.50

Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc (2009) 1.39

More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 1.31

Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Dig Dis Sci (2010) 1.16

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. Ther Clin Risk Manag (2010) 1.12

Osteoporosis and gastrointestinal disease. Gastroenterol Hepatol (N Y) (2010) 0.99

Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. Osteoporos Int (2010) 0.99

Current and future treatment options in osteoporosis. Eur J Clin Pharmacol (2011) 0.98

Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD). PLoS One (2012) 0.96

Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies. World J Gastroenterol (2012) 0.95

Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw. Head Face Med (2011) 0.93

Ginseng saponins and the treatment of osteoporosis: mini literature review. J Ginseng Res (2013) 0.92

Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies. Osteoporos Int (2012) 0.92

More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 0.91

A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study. PLoS One (2012) 0.91

Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database. BMJ Open (2012) 0.87

Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report. Int J Pediatr Endocrinol (2010) 0.85

Progress in osteoporosis and fracture prevention: focus on postmenopausal women. Arthritis Res Ther (2009) 0.85

Mechanisms of bone anabolism regulated by statins. Biosci Rep (2012) 0.85

Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies. Skeletal Radiol (2011) 0.82

Management of osteoporosis in the aging male: focus on zoledronic acid. Clin Interv Aging (2009) 0.82

Bisphosphonates for the treatment of osteoporosis: insights for clinicians. Ther Adv Chronic Dis (2010) 0.82

Management of osteoporosis among the elderly with other chronic medical conditions. Drugs Aging (2012) 0.82

Long-term safety concerns of antiresorptive therapy. Rheum Dis Clin North Am (2011) 0.81

Osteoporosis therapies: evidence from health-care databases and observational population studies. Calcif Tissue Int (2010) 0.81

Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol (2013) 0.81

Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice. PLoS One (2014) 0.80

RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv Drug Deliv Rev (2011) 0.80

Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study. J Bone Metab (2015) 0.80

Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management. Ther Adv Musculoskelet Dis (2009) 0.79

More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 0.79

More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 0.78

Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury. Osteoporos Int (2014) 0.78

The pharmacological management of osteoporosis. Mo Med (2011) 0.78

Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One (2015) 0.78

Esophageal stricture associated with alendronate use. CMAJ (2011) 0.77

Safety of drugs used in the treatment of osteoporosis. Ther Adv Drug Saf (2011) 0.77

Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis. BMJ Open (2015) 0.75

Bisphosphonates as potential adjuvants for patients with cancers of the digestive system. World J Gastroenterol (2016) 0.75

Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea. PLoS One (2016) 0.75

More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 0.75

Current options for the treatment of Paget's disease of the bone. Open Access Rheumatol (2009) 0.75

Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study. Osteoporos Int (2017) 0.75

Alendronate and risedronate: reports of severe bone, joint, and muscle pain. Arch Intern Med (2005) 1.99

Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr (2004) 1.84

Relationship between headache and depression in users of isotretinoin. Arch Dermatol (2005) 1.46

Use of antidiabetic drugs in the U.S., 2003-2012. Diabetes Care (2014) 1.44

Statin use and the risk of breast cancer. J Clin Epidemiol (2003) 1.29

Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002. Public Health Rep (2006) 1.18

Uterine sarcoma associated with tamoxifen use. N Engl J Med (2002) 1.11

Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J Clin Endocrinol Metab (2011) 1.06

Oral bisphosphonates and oesophageal cancer. BMJ (2010) 0.95

Finasteride in benign prostatic hyperplasia. N Engl J Med (2004) 0.80

Analyzing prescription drugs as causes of death on death certificates.. Public Health Rep (2004) 0.79